Wnt5a inhibits the proliferation and melanogenesis of melanocytes

International Journal of Medical Sciences

Volumn 10, Issue 6, 2013, Pages 699-706

  Zhang, Jie ^a   Li, Yan ^a   Wu, Yun ^a   Yang, Tian ^a   Yang, Ke ^a   Wang, Ruimin ^b   Yang, Jin ^a   Guo, Haiying ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Melanocyte; Melanogenesis; Proliferation; Wnt Ror2 pathway; Wnt5a

Indexed keywords

BROXURIDINE; MELANIN; MONOPHENOL MONOOXYGENASE; WNT5A PROTEIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; INHIBITION KINETICS; MELANOCYTE; MELANOGENESIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

MELANOCYTE; MELANOGENESIS; PROLIFERATION; WNT/ROR2 PATHWAY.; WNT5A;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MART-1 ANTIGEN; MELANINS; MELANOCYTES; MICE; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84876039602     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.5664     Document Type: Article

References (40)

1. Park HY, Kosmadaki M, Yaar M, Gilchrest BA. Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci. 2009;66:1493-506.
2. Thomas AJ, Erickson CA. The making of a melanocyte: the specification of melanoblasts from the neural crest. Pigment Cell Melanoma Res. 2008;21:598-610.
3. Nishimura EK. Melanocyte stem cells: a melanocyte reservoir in hair follicles for hair and skin pigmentation. Pigment Cell Melanoma Res. 2011; 24:401-10.
4. Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84:1155-228.
5. Yamaguchi Y, Brenner M, Hearing VJ. The regulation of skin pigmenta-tion. J Biol Chem. 2007;282:27557-61.
6. Passeron T, Mantoux F, Ortonne JP. Genetic disorders of pigmentation. Clin Dermatol. 2005;23:56-67.
7. Willert K, Brown JD, Danenberg E, et al. Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature. 2003;423:448-52.
8. Peng L, Ye L, Dong G, et al. WNT5A inhibits human dental papilla cell proliferation and migration. Biochem Biophys Res Commun. 2009;390:1072-8.
9. Valencia J, Hernandez-Lopez C, Martinez VG, et al. Wnt5a Skews Den-dritic Cell Differentiation to an Unconventional Phenotype with Toler-ogenic Features. Journal of Immunology. 2011;187:4129-39.
10. Yamagata K, Li X, Oneyama C, et al. Dissection of Wnt5a-Ror2 Signaling Leading to Matrix Metalloproteinase (MMP-13) Expression. Journal of Biological Chemistry. 2012;287:1588-99.
11. Kikuchi A, Yamamoto H, Kishida S. Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal. 2007;19:659-71.
12. Eisenmann DM. Wnt signaling. WormBook. 2005;:1-17.
13. Miller JR. The Wnts. Genome Biol. 2002;3:3001.
14. Dorsky RI, Moon RT, Raible DW. Control of neural crest cell fate by the Wnt signalling pathway. Nature. 1998;396:370-3.
15. Dunn KJ, Brady M, Ochsenbauer-Jambor C, Snyder S, Incao A, pavan WJ. WNT1 and WNT3a promote expansion of melanocytes through dis-tinct modes of action. Pigment Cell Research. 2005;18:167-80.
16. Ikeya M, Lee SM, Johnson JE, McMahon AP, Takada S. Wnt signalling required for expansion of neural crest and CNS progenitors. Nature. 1997;389:966-70.
17. Guo H, Yang K, Deng F, et al. Wnt3a inhibits proliferation but promotes melanogenesis of melan-a cells. Int J Mol Med. 2012;30:636-42.
18. Guo H, Yang K, Deng F, et al. Wnt3a promotes melanin synthesis of mouse hair follicle melanocytes. Biochem Biophys Res Commun. 2012;420:799-804.
19. Weeraratna AT, Jiang Y, Hostetter G, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002;1:279-88.
20. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for pro-gression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res. 2005;11:8606-14.
21. Da Forno PD, Prinqle JH, Hutchinson P, et al. WNT5A expression in-creases during melanoma progression and correlates with outcome. Clin Cancer Res. 2008; 14:5825-32.
22. Dissanayake SK, Olkhanud PB, O'Connell MP, et al. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res. 2008;68:10205-14.
23. Bennett DC, Cooper PJ, Hart IR. A line of non-tumorigenic mouse mel-anocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer. 1987;39:414-8.
24. Luo J, Deng ZL, Luo X, et al. A protocol for rapid generation of recom-binant adenoviruses using the AdEasy system. Nature Protocols. 2007;2:1236-47.
25. Bellei B, Maresca V, Flori E, Pitisci A, Larue L, Picardo M. p38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem. 2010;285:7288-99.
26. Peng Y, Kang Q, Cheng H, et al. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem. 2003;90:1149-65.
27. Semenov MV, Habas R, Macdonald BT, He X. SnapShot: Noncanonical Wnt Signaling Pathways. Cell. 2007;131:1378.
28. Nishita M, Itsukushima S, Nomachi A, et al. Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization. Mol Cell Biol. 2010;30:3610-9.
29. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434:843-50.
30. Kikuchi A, Kishida S, Yamamoto H. Regulation of Wnt signaling by protein-protein interaction and post-translational modifications. Ex-perimental and Molecular Medicine. 2006;38:1-10.
31. Weeraratna AT, Jiang Y, Hostetter G, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell. 2002;1:279-88.
32. Jenei V, Sherwood V, Howlin J, et al. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc Natl Acad Sci U S A. 2009;106:19473-8.
33. O'Connell MP, Fiori JL, Xu M, et al. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma. Oncogene. 2010; 29:34-44.
34. O'Connell MP, Fiori JL, Bauqher KM, et al. Wnt5A Activates the Cal-pain-Mediated Cleavage of Filamin A. Journal of Investigative Derma-tology. 2009;129:1782-9.
35. Liang HL, Chen Q, Coles AH, et al. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell. 2003;4:349-60.
36. Cheng CW, Yeh JC, Fan TP, Smith SK, Charnock-Jones DS. Wnt5a-mediated non-canonical Wnt signalling regulates human endo-thelial cell proliferation and migration. Biochem Biophys Res Commun. 2008;365:285-90.
37. Nomachi A, Nishita M, Inaba D, Enomoto M, Hamasaki M, Mianmi Y. Receptor tyrosine kinase Ror2 mediates Wnt5a-induced polarized cell migration by activating c-Jun N-terminal kinase via actin-binding pro-tein filamin A. Journal of Biological Chemistry. 2008;283:27973-81.
38. Yuan Y, Niu CC, Deng G, et al. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Int J Mol Med. 2011;27:63-9.
39. Schambony A, Wedlich D. Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway. Developmental Cell. 2007;12:779-92.
40. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol. 2003;162:899-908.